Vyzulta 0.024 % Ophthalmic Solution

RxCUI: 1988399
RxNorm name: Vyzulta 0.024 % Ophthalmic Solution
Display name: Vyzulta 0.024 % Ophthalmic Solution
Full name: Vyzulta 0.024 % Ophthalmic Solution
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Vyzulta	LATANOPROSTENE BUNOD	Bausch & Lomb Incorporated	60ce7900-a677-4fc2-88d0-1603baa9dbd4	2024-02-27	Warnings, Adverse reactions	Exact identifier rxcui: 1988399

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
60ce7900-a677-4fc2-88d0-1603baa9dbd4	VYZULTA 0.024 % Ophthalmic Solution [PSN] · latanoprostene bunod 0.24 MG/ML Ophthalmic Solution [Vyzulta] [SBD] · Vyzulta 0.024 % Ophthalmic Solution [SY] · Vyzulta 0.24 MG/ML Ophthalmic Solution [SY]	4	7	These highlights do not include all the information needed to use VYZULTA safely and effectively. See full prescribing information for VYZULTA. VYZULTA ® (latanoprostene bunod ophthalmic solution) 0.024%, for topical ophthalmic use Initial U.S. Approval: 2017	20240227